Citadel Advisors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-62,900
Closed -$6.43M 9326
2014
Q4
$6.43M Buy
62,900
+24,600
+64% +$2.36M 0.01% 1753
2014
Q3
$3.31M Sell
38,300
-300
-0.8% -$26.6K ﹤0.01% 2369
2014
Q2
$3.48M Sell
38,600
-700
-2% -$52.4K ﹤0.01% 2175
2014
Q1
$2.9M Buy
39,300
+6,800
+21% +$474K ﹤0.01% 2254
2013
Q4
$2.21M Sell
32,500
-10,500
-24% -$683K ﹤0.01% 2453
2013
Q3
$2.62M Sell
43,000
-51,075
-54% -$3.12M ﹤0.01% 2149
2013
Q2
$5.24M Buy
+94,075
New +$5.44M 0.01% 1529

Citadel Advisors's COV Position: Q4 2014 in Review

Citadel Advisors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 2,999,470 shares — an estimated $288M sold.

Citadel Advisors first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $259M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Citadel Advisors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
  • Citadel Advisors sold 2,999,470 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $288M.
  • Citadel Advisors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Citadel Advisors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $259M in Q3 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.